Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
The agreement involves the purchase of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be around $3.9 million.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million.
Placement Agent
Maxim Group LLC is the sole placement agent for the offering.
- The offering is part of Scienture Holdings' strategy to raise capital for its pharmaceutical operations.
- The effective shelf registration statement on Form S-3 allows the offering to proceed smoothly.
The registered direct offering represents a strategic move for Scienture Holdings, Inc. to secure funding for its pharmaceutical product development and distribution.